HEMATIDE

Welcome to the Brand page for “HEMATIDE”, which is offered here for Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, ischemia, myocardial infarction, congestive heart failure, renal failure, anoxia-induced cellular degeneration, hypoxia-induced cellular degeneration and stroke;.

Its status is currently believed to be active. Its class is unavailable. “HEMATIDE” is believed to be currently owned by “Affymax, Inc.”